Surfing on the Cardiovascular Frontier Wave

Klaus T. Preissner; William A. Boisvert; Derek J. Hausenloy

doi:10.1160/TH15-01-0086

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2015; 113(03): 439-440
DOI: 10.1160/TH15-01-0086

Theme Issue Editorial

Schattauer GmbH

Surfing on the Cardiovascular Frontier Wave

Authors

Klaus T. Preissner

¹Department Biochemistry, Medical School, Justus-Liebig-University, Giessen, Germany
William A. Boisvert

²Center for Cardiovascular Research, John A. Burns School of Medicine, University of Hawaii, Honolulu, Hawaii, USA
Derek J. Hausenloy

³The Hatter Cardiovascular Institute, University College, London, UK

Abstract

Full Text

References

1 Colasante C. et al. Peroxisomes in cardiomyocytes and the peroxisome / peroxisome proliferator-activated receptor-loop. Thromb Haemost 2015; 113: 452-463.
2 Cabrera-Fuentes HA. et al. RNase1 prevents the damaging interplay between extracellular RNA and tumour necrosis factor-α in cardiac ischae-mia/reperfusion injury. Thromb Haemost 2014; 112: 1110-1119.
3 Cabrera-Fuentes HA. et al. Regulation of mono-cyte/macrophage polarisation by extracellular RNA. Thromb Haemost 2015; 113: 473-481.
4 Simsekyilmaz S. et al. Role of extracellular RNA in atherosclerotic plaque formation in mice. Circulation 2014; 129: 598-606.
5 Vogel CW. et al. Complement depletion with humanised cobra venom factor: Efficacy in preclinical models of vascular diseases. Thromb Haemost 2015; 113: 548-552.
6 Rose AH, Hoffmann PR. Selenoproteins and cardiovascular stress. Thromb Haemost 2015; 113: 494-504.
7 Han X, Boisvert WA. Interleukin-10 protects against atherosclerosis by modulating multiple atherogenic macrophage function. Thromb Haemost 2015; 113: 505-512.
8 Patra C. et al. Vascularisation for cardiac tissue engineering: the extracellular matrix. Thromb Haemost 2015; 113: 532-547.
9 Ong SB. et al. Akt protects the heart against ischaemia-reperfusion injury by modulating mitochondrial morphology. Thromb Haemost 2015; 113: 513-521.
10 Hall AR. et al. Mitochondrial fusion and fission proteins: novel therapeutic targets for combating cardiovascular disease. Br J Pharmacol 2014; 171: 1890-1906.
11 Ong SB. et al. Inhibiting mitochondrial fission protects the heart against ischaemia/reperfusion injury. Circulation 2010; 121: 2012-2022.
12 Fernandez-Sanz C. et al. Altered FoF1 ATP synthase and susceptibility to mitochondrial permeability transition pore during ischaemia and reperfusion in aging cardiomyocytes. Thromb Haemost 2015; 113: 441-451.
13 Giorgio V. et al. Dimers of mitochondrial ATP synthase form the permeability transition pore. Proc Natl Acad Sci USA 2013; 110: 5887-5892.
14 Carraro M. et al. Channel formation by yeast F-ATP synthase and the role of dimerisation in the mitochondrial permeability transition. J Biol Chem 2014; 289: 15980-15985.
15 Yellon DM, Hausenloy DJ. Myocardial reperfusion injury. N Engl J Med 2007; 357: 1121-1135.
16 Schreckenberg R. et al. Mechanism and consequences of the shift in cardiac arginine metabolism following ischaemia and reperfusion in rats. Thromb Haemost 2015; 113: 482-493.
17 Simsekyilmaz S. et al. Progress in interventional cardiology: challenges for the future. Thromb Haemost 2015; 113: 464-472.
18 Ferrazzi F. et al. Gene network analysis: from heart development to cardiac therapy. Thromb Haemost 2015; 113: 522-531